Cargando…

Stem cell therapy for heart failure: Medical breakthrough, or dead end?

Heart failure continues to be one of the leading causes of morbidity and mortality worldwide. Myocardial infarction is the primary causative agent of chronic heart failure resulting in cardiomyocyte necrosis and the subsequent formation of fibrotic scar tissue. Current pharmacological and non-pharma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rheault-Henry, Mathieu, White, Ian, Grover, Diya, Atoui, Rony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080540/ https://www.ncbi.nlm.nih.gov/pubmed/33959217 http://dx.doi.org/10.4252/wjsc.v13.i4.236

Ejemplares similares

High-resolution manometry in diagnostics and evaluation of therapy effectiveness in patients with eosinophilic esophagitis – underestimated breakthrough or dead end?
por: Sarbinowska, Joanna A., et al.
Publicado: (2019)

Therapeutic use of stem cells for cardiovascular disease
por: Faiella, Whitney, et al.
Publicado: (2016)

Therapeutic Use of Stem Cells for Myocardial Infarction
por: Madigan, Mariah, et al.
Publicado: (2018)

Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review
por: Faiella, Whitney, et al.
Publicado: (2016)

The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease
por: Liu, Chuanbin, et al.
Publicado: (2021)

Advanced Therapies For End-Stage Heart Failure
por: Katz, Jason N, et al.
Publicado: (2015)

Cardiac Resynchronization Therapy prevents progression of renal failure in heart failure patients
por: Jeevanantham, Vinodh, et al.
Publicado: (2016)

Breakthrough in heart failure with preserved ejection fraction: are we there yet?
por: Lim, Shir Lynn, et al.
Publicado: (2016)

Dead but Not Dead End: Multifunctional Role of Dead Organs Enclosing Embryos in Seed Biology
por: Grafi, Gideon
Publicado: (2020)

Breakthroughs in the treatment of heart failure with mildly reduced and preserved ejection fraction
por: Talha, Khawaja M., et al.
Publicado: (2022)

The Dead Failure, Limited
por: Garraway, Edward
Publicado: (1887)

Editorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?
por: Boltze, Johannes, et al.
Publicado: (2020)

A medical "dead end" job? The recruitment and career progression of the Edwardian school medical officer.
por: Hirst, J D
Publicado: (2000)

Audicor Remote Patient Monitoring: FDA Breakthrough Device and Technology for Heart Failure Management
por: Fudim, Marat, et al.
Publicado: (2022)

Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research
por: Laso-García, Fernando, et al.
Publicado: (2019)

Beta-blocker therapy in pediatric heart failure: 50 years lost to improve pharmacotherapy of a deadly disease
por: Buchhorn, Reiner
Publicado: (2021)

Treatment of alcoholic hepatitis: is this a “dead-end”?
por: Akriviadis, Evangelos, et al.
Publicado: (2016)

On Staying Grounded and Avoiding Quixotic Dead Ends
por: Barsalou, Lawrence W.
Publicado: (2016)

The “Dead-End Tract” and Its Role in Arrhythmogenesis
por: de Vries, Lennart, et al.
Publicado: (2016)

Clostridium chauvoei, an Evolutionary Dead-End Pathogen
por: Rychener, Lorenz, et al.
Publicado: (2017)

Mad Cow Disease: Dead-End Host?
por: Almond, Jeffrey W
Publicado: (1996)

Angiotensin receptor/neprilysin inhibitor—a breakthrough in chronic heart failure therapy: summary of subanalysis on PARADIGM-HF trial findings
por: Książczyk, Marcin, et al.
Publicado: (2019)

EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction
por: Wagdy, Kerolos, et al.
Publicado: (2021)

The Living and the Dead
por: White, Kirke
Publicado: (1893)

High-output congestive heart failure: a potentially deadly complication of thyroid storm
por: Taylor, Gregory M, et al.
Publicado: (2019)

Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy
por: Wu, Yafei, et al.
Publicado: (2020)

Combination stem cell therapy for heart failure
por: Ichim, Thomas E, et al.
Publicado: (2010)

Stem cell therapy for congestive heart failure
por: Gunduz, E, et al.
Publicado: (2011)

An Ultra Scale-Down Analysis of the Recovery by Dead-End Centrifugation of Human Cells for Therapy
por: Delahaye, M, et al.
Publicado: (2015)

The road to improving cardiac resynchronization therapy outcomes: Paved with gold or an alchemist’s dead end?
por: Deering, Thomas F., et al.
Publicado: (2022)

Dead End Metabolites - Defining the Known Unknowns of the E. coli Metabolic Network
por: Mackie, Amanda, et al.
Publicado: (2013)

Dead Time in the LAr Calorimeter Front-End Readout
por: Gingrich, D M, et al.
Publicado: (2002)

Corrigendum: Clostridium chauvoei, an Evolutionary Dead-End Pathogen
por: Rychener, Lorenz, et al.
Publicado: (2018)

Biomechanics of Tetrahymena escaping from a dead end
por: Ishikawa, Takuji, et al.
Publicado: (2018)

Antioxidants in the Fight Against Atherosclerosis: Is This a Dead End?
por: Toledo-Ibelles, Paola, et al.
Publicado: (2018)

Dilemmas in end-stage heart failure
por: Chen-Scarabelli, Carol, et al.
Publicado: (2015)

Hearts Not Dead after Circulatory Death
por: Tevaearai Stahel, Hendrik T., et al.
Publicado: (2015)

Transcripts that associate with the RNA binding protein, DEAD-END (DND1), in embryonic stem (ES) cells
por: Zhu, Rui, et al.
Publicado: (2011)

Enhanced Heart Failure in Redox‐Dead Cys17Ser PKARIα Knock‐In Mice
por: Islam, M. M. Towhidul, et al.
Publicado: (2021)

End-of-Life Care for End-stage Heart Failure Patients
por: Lee, Ju-Hee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ipboeeuf7c50arpvernfsi82b